Annual SG&A
$17.11 M
+$3.60 M+26.68%
31 December 2023
Summary:
ProShares UltraPro Short Nasdaq Biotechnology annual selling, general & administrative expenses is currently $17.11 million, with the most recent change of +$3.60 million (+26.68%) on 31 December 2023. ZBIO annual SG&A is now at all-time high.ZBIO Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$7.45 M
+$1.56 M+26.45%
30 September 2024
Summary:
ProShares UltraPro Short Nasdaq Biotechnology quarterly selling, general & administrative expenses is currently $7.45 million, with the most recent change of +$1.56 million (+26.45%) on 30 September 2024. Over the past year, it has increased by +$2.43 million (+48.37%). ZBIO quarterly SG&A is now at all-time high.ZBIO Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$1.12 B
-$128.97 M-13.02%
30 September 2024
Summary:
ProShares UltraPro Short Nasdaq Biotechnology TTM selling, general & administrative expenses is currently -$1.12 billion, with the most recent change of -$128.97 million (-13.02%) on 30 September 2024. Over the past year, it has dropped by -$1.12 billion (-22384.47%). ZBIO TTM SG&A is now -443.97% below its all-time high of $22.64 million, reached on 30 September 2024.ZBIO TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZBIO Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +26.7% | +48.4% | -10000.0% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
ZBIO Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +26.7% | at high | +70.9% | -444.0% | at low |
| 5 y | 5 years | at high | +26.7% | at high | +70.9% | -444.0% | at low |
| alltime | all time | at high | +26.7% | at high | +70.9% | -444.0% | at low |
ProShares UltraPro Short Nasdaq Biotechnology Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $7.45 M(+26.4%) | $22.64 M(+12.0%) |
| June 2024 | - | $5.89 M(+19.5%) | $20.21 M(+41.2%) |
| Mar 2024 | - | $4.93 M(+13.1%) | $14.32 M(+52.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $17.11 M(+26.7%) | $4.36 M(-13.2%) | $9.38 M(+86.8%) |
| Sept 2023 | - | $5.02 M | $5.02 M |
| Dec 2022 | $13.51 M | - | - |
FAQ
- What is ProShares UltraPro Short Nasdaq Biotechnology annual selling, general & administrative expenses?
- What is the all time high annual SG&A for ProShares UltraPro Short Nasdaq Biotechnology?
- What is ProShares UltraPro Short Nasdaq Biotechnology annual SG&A year-on-year change?
- What is ProShares UltraPro Short Nasdaq Biotechnology quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for ProShares UltraPro Short Nasdaq Biotechnology?
- What is ProShares UltraPro Short Nasdaq Biotechnology quarterly SG&A year-on-year change?
- What is ProShares UltraPro Short Nasdaq Biotechnology TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for ProShares UltraPro Short Nasdaq Biotechnology?
- What is ProShares UltraPro Short Nasdaq Biotechnology TTM SG&A year-on-year change?
What is ProShares UltraPro Short Nasdaq Biotechnology annual selling, general & administrative expenses?
The current annual SG&A of ZBIO is $17.11 M
What is the all time high annual SG&A for ProShares UltraPro Short Nasdaq Biotechnology?
ProShares UltraPro Short Nasdaq Biotechnology all-time high annual selling, general & administrative expenses is $17.11 M
What is ProShares UltraPro Short Nasdaq Biotechnology annual SG&A year-on-year change?
Over the past year, ZBIO annual selling, general & administrative expenses has changed by +$3.60 M (+26.68%)
What is ProShares UltraPro Short Nasdaq Biotechnology quarterly selling, general & administrative expenses?
The current quarterly SG&A of ZBIO is $7.45 M
What is the all time high quarterly SG&A for ProShares UltraPro Short Nasdaq Biotechnology?
ProShares UltraPro Short Nasdaq Biotechnology all-time high quarterly selling, general & administrative expenses is $7.45 M
What is ProShares UltraPro Short Nasdaq Biotechnology quarterly SG&A year-on-year change?
Over the past year, ZBIO quarterly selling, general & administrative expenses has changed by +$2.43 M (+48.37%)
What is ProShares UltraPro Short Nasdaq Biotechnology TTM selling, general & administrative expenses?
The current TTM SG&A of ZBIO is -$1.12 B
What is the all time high TTM SG&A for ProShares UltraPro Short Nasdaq Biotechnology?
ProShares UltraPro Short Nasdaq Biotechnology all-time high TTM selling, general & administrative expenses is $22.64 M
What is ProShares UltraPro Short Nasdaq Biotechnology TTM SG&A year-on-year change?
Over the past year, ZBIO TTM selling, general & administrative expenses has changed by -$1.12 B (-22384.47%)